Senvelgo Oral Solution for Cats

Description

Senvelgo (velagliflozin) is a modern, liquid medication designed to manage feline diabetes mellitus without the need for traditional insulin injections. It is classified as a sodium-glucose cotransporter 2 (SGLT2) inhibitor. This oral solution works by preventing the kidneys from reabsorbing glucose back into the bloodstream, allowing excess sugar to be excreted through the urine. This process effectively reduces hyperglycaemia (high blood sugar) in cats with non-insulin-dependent diabetes, offering a simplified treatment option for pet owners.

Key Information

• Active Ingredient: Velagliflozin L-proline monohydrate.

• Approved Species: Cat.

• Uses: Reduction of hyperglycaemia in cats with non-insulin-dependent diabetes mellitus.

• Form: Oral solution.

• Route of Administration: Oral (once daily, either directly in the mouth or with a small amount of food).

Prescription Required

Senvelgo is a prescription-only medication. A valid prescription from a licensed veterinarian is required for purchase. Professional screening is vital before starting this medication to ensure the cat has non-insulin-dependent diabetes and healthy ketone levels. Regular veterinary monitoring is necessary to track glucose levels and ensure the treatment remains safe and effective.